Regular monitoring is essential for patients on DMARDs to track:
- Liver function tests to detect hepatotoxicity. - Complete blood count (CBC) to monitor for bone marrow suppression. - Renal function tests for nephrotoxicity. - Regular gynecological exams to assess reproductive health.